Skip to main content
Biomolecules & Therapeutics logoLink to Biomolecules & Therapeutics
. 2025 Jan 1;33(1):233. doi: 10.4062/biomolther.2024.006

Erratum to "Investigating the Immune-Stimulating Potential of β-Glucan from Aureobasidium pullulans in Cancer Immunotherapy" [Biomol Ther 32(5), 556-567 (2024)]

Jae-Hyeon Jeong 1,2,3,, Dae-Joon Kim 1,2,3,, Seong-Jin Hong 4,5,, Jae-Hee Ahn 1,3, Dong-Ju Lee 1,2,3, Ah-Ra Jang 6, Sungyun Kim 1,2, Hyun-Jong Cho 1,2, Jae-Young Lee 6, Jong-Hwan Park 6,7, Young-Min Kim 4,5,*, Hyun-Jeong Ko 1,2,3,6,*
PMCID: PMC11704399  PMID: 39725478

The following content was omitted during the publication process.

CONFLICT OF INTEREST

The authors declare that this study was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.

ACKNOWLEDGMENTS

This work was supported by the Technology Development Program (S3318540), funded by the Ministry of SMEs and Startups (MSS, Korea).

AUTHOR CONTRIBUTIONS

H-JK and Y-MK prepared the concept and designed the study. J-HJ, D-JK,and H-JK wrote the manuscript. J-HJ, D-JK, S-JH,D-JL, andS-YK performed the in vitro and in vivo experiments and analyzed the data. J-HA, A-RJ, and H-JCperformed data curation.H-JK supervised the entire study and obtained funding. All authors contributed to the article and approved the submitted version.


Articles from Biomolecules & Therapeutics are provided here courtesy of Korean Society of Applied Pharmacology

RESOURCES